Idorsia.com
  • Home
  • About Idorsia
    • Idorsia today
      • Our strategy
      • Our drug discovery approach
      • Our pipeline
      • Our locations
      • History
    • Idorsia people
      • Our organization
      • Our behaviors
      • Leaders
      • Board of Directors
    • Target diseases
      • Fabry disease
      • Insomnia
      • Cerebral vasospasm
      • Resistant Hypertension
      • Lupus
      • AMI
    • Partnerships
  • Our responsibilities
    • Our Approach
    • Our Employees
    • Serving Patients
    • Environment
    • Our Communities
    • Governance
      • Internal organization of the Board
      • Compensation governance
      • Policies & Charters
  • Investors
    • Our equity story
      • Company strategy
      • Development Pipeline
      • Corporate Governance & Sustainability
    • Financial information
      • Financial overview
      • Company funding
      • Financial archive
    • Corporate Reports
    • News & Events
      • Media releases
      • Annual General Meeting
      • Pipeline webcasts
      • Financial reporting webcasts
    • Stock information
      • Stock overview
      • Stock chart tool
      • Covering analysts
      • Consensus estimate
  • Media
    • News archive
    • Media center
    • Social media
    • Resources in German
  • Careers
    • Working@Idorsia
      • Recruitment, Development & Retention
      • Diversity & Inclusion
      • Recognition
      • Compensation principles
      • Health, Safety & Well-being
    • Job opportunities
    • Living in Basel
    • FAQ
      • Privacy policy
  • Contact
More opportunities&nbsp;&ndash;<br />Expanding the horizonMore opportunities&nbsp;&ndash;<br />Expanding the horizon

Stay informed

More opportunities –
Expanding the horizon

Thank you for subscribing for the ‘Stay Informed’ service of Idorsia Ltd.

To best serve your interest, Idorsia offers an electronic ‘Stay Informed’ service. With this service you have the possibility to automatically receive Idorsia's Media Releases directly to your inbox. In addition, if you provide your mobile phone number, we will send you an alert via SMS when the media release is published

1) To register for the ‘Stay Informed’ service, please fill in this form and click ‘Submit’.

2) To unsubscribe from the 'Stay Informed' service, please click here.

 

Not all mandatory fields are filled in. Please fill in all mandatory fields.

Distribution language
Preferred distribution language*
 
 
Your details

1 Please include your international country code, e.g. 31612345678

Fields marked in * must be completed to guarantee effective processing of your message.
 

In processing your personal data, Idorsia will fully comply with internationally recognized standards of data protection. In doing so, Idorsia ensures compliance of its staff with strict standards of security and confidentiality.

You've been successfully unsubscribed.

To unsubscribe from the 'Stay informed' service, please enter your e-mail address below, and click 'Unsubscribe'.

Your login was not successful. Your e-mail address was not found in our database, or did not match the password entered.

Fields marked in * must be completed to guarantee effective processing of your message.

In processing your personal data, Idorsia will fully comply with internationally recognized standards of data protection. In doing so, Idorsia ensures compliance of its staff with strict standards of security and confidentiality.

Your e-mail address was not found in our database. Please check your e-mail address and try again.

Fields marked in * must be completed to guarantee effective processing of your message.

In processing your personal data, Idorsia will fully comply with internationally recognized standards of data protection. In doing so, Idorsia ensures compliance of its staff with strict standards of security and confidentiality.

Error!

An unexpected error occurred. Please try again.

Contact overview

Contact overview
  • Overview of contacts click here...
Follow us:
Viewing options

This website is subject to the terms and conditions outlined in the legal and privacy statement.

Last update: 04.01.2021

Legal & privacy statement|Site map|Cookie policy|Webmaster

Copyright © 2021 Idorsia Pharmaceuticals Ltd